What we're reading, August 29, 2016: Audit finds Medicare Advantage plans overcharged the government; enrollment on the Affordable Care Act's exchanges less than half of initial prediction; and California bill to protect consumers from surprise medical bills divides physicians.
Some Medicare Advantage (MA) plans are overcharging the government by overstating the severity of certain medical conditions. According to NPR, as the popularity of MA plans grows, so does the controversy over the accuracy of billings. The formula used pays MA plans higher rates for sicker patients, and audits of 37 MA programs found overpayments in 2007. The disease categories “diabetes with complications” and “major depressive bipolar and paranoid disorders” trigger large payments, but auditors found insufficient evidence nearly half the time that these diagnoses were accurate.
Bad news for the Affordable Care Act (ACA)’s insurance exchanges keeps rolling in. First, there were multiple reports of insurers, such as Aetna, reducing their involvement in the exchanges. Now, it has been revealed that the number of people signed up for coverage is less than half of initial forecasts, reported The Washington Post. The Congressional Budget Office had estimated that 24 million people would sign up for coverage on the ACA exchanges in 2016, but just 11.1 million had signed up as of March 2016. To be fair, the initial prediction from the Congressional Budget Office had expected more people to lose insurance through their employers, which would force them to get coverage on the exchanges.
California legislators have once again introduced a bill to protect patients from surprise medical bills. The bill would require consumers to pay the equivalent of in-network rates if they are treated by an out-of-network provider during a covered service, according to STAT. For example, if an out-of-network radiologist reads an X-ray covered by insurance, the consumer pays the in-network rate. A similar bill had been introduced last year. Independent physicians are arguing that the bill would encourage insurers to keep narrow networks and ignore small practices.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More